BRIEF-Castle Biosciences Q3 Revenue USD 83.043 Million Vs. IBES Estimate USD 71.2 Million

Reuters
Nov 04
BRIEF-<a href="https://laohu8.com/S/CSTL">Castle Biosciences</a> Q3 Revenue USD 83.043 Million Vs. IBES Estimate USD 71.2 Million

Nov 03 (Reuters) - Castle Biosciences Q3 pretax profit USD -386 thousand.

  • Q3 operating expenses USD 89.847 million
  • Q3 net income USD -501 thousand
  • Q3 operating income USD -6.804 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10